|
|
||||||||
The Journal of Immunology, Vol 140, Issue 5 1490-1495, Copyright © 1988 by American Association of Immunologists
ARTICLES |
RR Caspi, FG Roberge, CC Chan, B Wiggert, GJ Chader, LA Rozenszajn, Z Lando and RB Nussenblatt
Laboratory of Immunology, National Eye Institute, Bethesda, MD 20892.
Experimental autoimmune uveoretinitis (EAU) is an organ-specific, T lymphocyte-mediated autoimmune disease, which serves as a model for several human ocular inflammations of an apparently autoimmune nature. EAU pathology in some rodents and in monkeys can readily be induced by immunization with several different retinal proteins; however, advancing research into the cellular mechanisms of this disease has raised the need for an EAU model in an immunologically and genetically well defined species. We report here the induction of EAU in the mouse, which has hitherto been considered a species refractory to EAU, with two retinal Ag, the retinal soluble Ag and the interphotoreceptor retinoid-binding protein. Although all the mouse strains tested exhibited lymphocyte responses and antibody titers to both retinal Ag, EAU was inducible in only some of the strains, and the uveitogenic responses to retinal soluble Ag and interphotoreceptor retinoid-binding protein appeared to be mutually exclusive. The EAU model in mice was found to differ in several respects from the EAU model in other rodent species. Induction of the disease was achieved with a relatively high dose of Ag and an intensified immunization protocol, and the onset of disease was later, the duration was longer, and the course was less acute. Anterior segment involvement was slight or nonexistent, and damage to the retina and uvea was of a focal rather than of a diffuse nature. Murine EAU appeared to approximate some types of human uveitis more closely than the EAU models described in other rodent species with respect to its pathologic manifestations as well as its more chronic course. The relatively longer duration of the active stage of disease in murine EAU should facilitate therapeutic intervention in established disease, which was not feasible in the more acute models of EAU. The extensive knowledge of the immunologic parameters of the mouse and the availability of genetically defined strains should be of great value in the study of cellular mechanisms and immunogenetics of ocular autoimmune disease.
This article has been cited by other articles:
![]() |
Z. Li, B. Liu, A. Maminishkis, S. P. Mahesh, S. Yeh, J. Lew, W. K. Lim, H. N. Sen, G. Clarke, R. Buggage, et al. Gene Expression Profiling in Autoimmune Noninfectious Uveitis Disease J. Immunol., October 1, 2008; 181(7): 5147 - 5157. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. E. Raveney, D. A. Copland, L. B. Nicholson, and A. D. Dick Fingolimod (FTY720) as an Acute Rescue Therapy for Intraocular Inflammatory Disease Arch Ophthalmol, October 1, 2008; 126(10): 1390 - 1395. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Cortes, D. Avichezer, P. B. Silver, D. Luger, M. J. Mattapallil, C.-C. Chan, and R. R. Caspi Inhibitory peptide analogs derived from a major uveitogenic epitope protect from antiretinal autoimmunity by inducing type 2 and regulatory T cells J. Leukoc. Biol., August 1, 2008; 84(2): 577 - 585. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Cortes, M. J. Mattapallil, P. B. Silver, L. A. Donoso, G. I. Liou, W. Zhu, C.-C. Chan, and R. R. Caspi Repertoire Analysis and New Pathogenic Epitopes of IRBP in C57BL/6 (H-2b) and B10.RIII (H-2r) Mice Invest. Ophthalmol. Vis. Sci., May 1, 2008; 49(5): 1946 - 1956. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. W. T. Lau, S. Biester, R. J. Cornall, and J. V. Forrester Lipopolysaccharide-Activated IL-10-Secreting Dendritic Cells Suppress Experimental Autoimmune Uveoretinitis by MHCII-Dependent Activation of CD62L-Expressing Regulatory T Cells J. Immunol., March 15, 2008; 180(6): 3889 - 3899. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Yoshimura, K.-H. Sonoda, Y. Miyazaki, Y. Iwakura, T. Ishibashi, A. Yoshimura, and H. Yoshida Differential roles for IFN-{gamma} and IL-17 in experimental autoimmune uveoretinitis Int. Immunol., February 1, 2008; 20(2): 209 - 214. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Oh-i, H. Keino, H. Goto, N. Yamakawa, M. Takeuchi, M. Usui, and T. Iwasaki Upregulation of neurotrophic factor-related gene expression in retina with experimental autoimmune uveoretinitis by intravitreal injection of tacrolimus (FK506) Br. J. Ophthalmol., November 1, 2007; 91(11): 1537 - 1540. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. B. Su, R. S. Grajewski, D. Luger, R. K. Agarwal, P. B. Silver, J. Tang, J. Tuo, C.-C. Chan, and R. R. Caspi Altered Chemokine Profile Associated with Exacerbated Autoimmune Pathology under Conditions of Genetic Interferon-{gamma} Deficiency Invest. Ophthalmol. Vis. Sci., October 1, 2007; 48(10): 4616 - 4625. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Copland, C. J. Calder, B. J.E. Raveney, L. B. Nicholson, J. Phillips, H. Cherwinski, M. Jenmalm, J. D. Sedgwick, and A. D. Dick Monoclonal Antibody-Mediated CD200 Receptor Signaling Suppresses Macrophage Activation and Tissue Damage in Experimental Autoimmune Uveoretinitis Am. J. Pathol., August 1, 2007; 171(2): 580 - 598. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kitamura, K. Iwabuchi, N. Kitaichi, S. Kon, H. Kitamei, K. Namba, K. Yoshida, D. T. Denhardt, S. R. Rittling, S. Ohno, et al. Osteopontin Aggravates Experimental Autoimmune Uveoretinitis in Mice J. Immunol., May 15, 2007; 178(10): 6567 - 6572. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Lambe, J. C. H. Leung, H. Ferry, T. Bouriez-Jones, K. Makinen, T. L. Crockford, H. R. Jiang, J. M. Nickerson, L. Peltonen, J. V. Forrester, et al. Limited Peripheral T Cell Anergy Predisposes to Retinal Autoimmunity J. Immunol., April 1, 2007; 178(7): 4276 - 4283. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Oh-i, H. Keino, H. Goto, N. Yamakawa, K. Murase, Y. Usui, T. Kezuka, J.-i. Sakai, M. Takeuchi, and M. Usui Intravitreal injection of Tacrolimus (FK506) suppresses ongoing experimental autoimmune uveoretinitis in Rats Br. J. Ophthalmol., February 1, 2007; 91(2): 237 - 242. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-H. Sonoda, T. Yoshimura, A. Takeda, T. Ishibashi, S. Hamano, and H. Yoshida WSX-1 plays a significant role for the initiation of experimental autoimmune uveitis Int. Immunol., January 1, 2007; 19(1): 93 - 98. [Abstract] [Full Text] [PDF] |
||||
![]() |
H Keino, M Takeuchi, Y Usui, T Hattori, N Yamakawa, T Kezuka, J-I Sakai, and M Usui Supplementation of CD4+CD25+ regulatory T cells suppresses experimental autoimmune uveoretinitis Br. J. Ophthalmol., January 1, 2007; 91(1): 105 - 110. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. T. Hikita, B. P. Vistica, H. R. Jones, J. R. Keswani, M. M. Watson, V. R. Ericson, G. S. Ayoub, I. Gery, and D. O. Clegg Osteopontin is proinflammatory in experimental autoimmune uveitis. Invest. Ophthalmol. Vis. Sci., October 1, 2006; 47(10): 4435 - 4443. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Takase, C.-R. Yu, D.-I. Ham, C.-C. Chan, J. Chen, B. P. Vistica, E. F. Wawrousek, S. K. Durum, C. E. Egwuagu, and I. Gery Inflammatory processes triggered by TCR engagement or by local cytokine expression: differences in profiles of gene expression and infiltrating cell populations J. Leukoc. Biol., September 1, 2006; 80(3): 538 - 545. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Terrada, S. Fisson, Y. De Kozak, M. Kaddouri, P. Lehoang, D. Klatzmann, B. L. Salomon, and B. Bodaghi Regulatory T cells control uveoretinitis induced by pathogenic Th1 cells reacting to a specific retinal neoantigen. J. Immunol., June 15, 2006; 176(12): 7171 - 7179. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kitamei, K. Iwabuchi, K. Namba, K. Yoshida, Y. Yanagawa, N. Kitaichi, M. Kitamura, S. Ohno, and K. Onoe Amelioration of experimental autoimmune uveoretinitis (EAU) with an inhibitor of nuclear factor-{kappa}B (NF-{kappa}B), pyrrolidine dithiocarbamate J. Leukoc. Biol., June 1, 2006; 79(6): 1193 - 1201. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Deeg, B. Amann, A. J. Raith, and B. Kaspers Inter- and Intramolecular Epitope Spreading in Equine Recurrent Uveitis Invest. Ophthalmol. Vis. Sci., February 1, 2006; 47(2): 652 - 656. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. B. Su, P. B. Silver, R. S. Grajewski, R. K. Agarwal, J. Tang, C.-C. Chan, and R. R. Caspi Essential Role of the MyD88 Pathway, but Nonessential Roles of TLRs 2, 4, and 9, in the Adjuvant Effect Promoting Th1-Mediated Autoimmunity J. Immunol., November 15, 2005; 175(10): 6303 - 6310. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Takeuchi, Y. Usui, M. Takeuchi, T. Hattori, T. Kezuka, J. Suzuki, Y. Okunuki, T. Iwasaki, M. Haino, K. Matsushima, et al. CCR5-Deficient Mice Develop Experimental Autoimmune Uveoretinitis in the Context of a Deviant Effector Response Invest. Ophthalmol. Vis. Sci., October 1, 2005; 46(10): 3753 - 3760. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.-K. Lim, C. Fujimoto, R. Ursea, S. P. Mahesh, P. Silver, C.-C. Chan, I. Gery, and R. B. Nussenblatt Suppression of Immune-Mediated Ocular Inflammation in Mice by Interleukin 1 Receptor Antagonist Administration Arch Ophthalmol, July 1, 2005; 123(7): 957 - 963. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. P. Martin, L. V. de Moraes, C. E. Tadokoro, A. G. Commodaro, E. Urrets-Zavalia, G. A. Rabinovich, J. Urrets-Zavalia, L. V. Rizzo, and H. M. Serra Administration of a Peptide Inhibitor of {alpha}4-Integrin Inhibits the Development of Experimental Autoimmune Uveitis Invest. Ophthalmol. Vis. Sci., June 1, 2005; 46(6): 2056 - 2063. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Kitaichi, K. Namba, and A. W. Taylor Inducible immune regulation following autoimmune disease in the immune-privileged eye J. Leukoc. Biol., April 1, 2005; 77(4): 496 - 502. [Abstract] [Full Text] [PDF] |
||||
![]() |
M Zierhut, N Stubiger, K Siepmann, and C M. Deuter MMF and eye disease Lupus, March 1, 2005; 14(3_suppl): s50 - s54. [Abstract] [PDF] |
||||
![]() |
M. Zierhut, N. Stubiger, K. Siepmann, and C. Deuter MMF and eye disease Lupus, January 1, 2005; 14(1_suppl): s50 - s54. [Abstract] [PDF] |
||||
![]() |
S. Bo Su, P. B. Silver, P. Wang, C.-C. Chan, and R. R. Caspi Cholera Toxin Prevents Th1-Mediated Autoimmune Disease by Inducing Immune Deviation J. Immunol., July 15, 2004; 173(2): 755 - 761. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Deeg, S. Reese, H. Gerhards, G. Wildner, and B. Kaspers The Uveitogenic Potential of Retinal S-Antigen in Horses Invest. Ophthalmol. Vis. Sci., July 1, 2004; 45(7): 2286 - 2292. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Takeuchi, H. Keino, T. Kezuka, M. Usui, and O. Taguchi Immune Responses to Retinal Self-Antigens in CD25+CD4+ Regulatory T-Cell-Depleted Mice Invest. Ophthalmol. Vis. Sci., June 1, 2004; 45(6): 1879 - 1886. [Abstract] [Full Text] [PDF] |
||||
![]() |
D.-I. Ham, S. J. Kim, J. Chen, B. P. Vistica, R. N. Fariss, R. S. Lee, E. F. Wawrousek, H. Takase, C.-R. Yu, C. E. Egwuagu, et al. Central Immunotolerance in Transgenic Mice Expressing a Foreign Antigen under Control of the Rhodopsin Promoter Invest. Ophthalmol. Vis. Sci., March 1, 2004; 45(3): 857 - 862. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Xu, A. Manivannan, H.-R. Jiang, J. Liversidge, P. F. Sharp, J. V. Forrester, and I. J. Crane Recruitment of IFN-{gamma}-Producing (Th1-Like) Cells into the Inflamed Retina In Vivo Is Preferentially Regulated by P-Selectin Glycoprotein Ligand 1:P/E-Selectin Interactions J. Immunol., March 1, 2004; 172(5): 3215 - 3224. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Avichezer, R. S. Grajewski, C.-C. Chan, M. J. Mattapallil, P. B. Silver, J. A. Raber, G. I. Liou, B. Wiggert, G. M. Lewis, L. A. Donoso, et al. An Immunologically Privileged Retinal Antigen Elicits Tolerance: Major Role for Central Selection Mechanisms J. Exp. Med., December 1, 2003; 198(11): 1665 - 1676. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Xu, P. B. Silver, T. K. Tarrant, C.-C. Chan, and R. R. Caspi TGF-{beta} Inhibits Activation and Uveitogenicity of Primary but Not of Fully Polarized Retinal Antigen-Specific Memory-Effector T Cells Invest. Ophthalmol. Vis. Sci., November 1, 2003; 44(11): 4805 - 4812. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. B. Su, P. B. Silver, P. Wang, C.-C. Chan, and R. R. Caspi Dissociating the Enhancing and Inhibitory Effects of Pertussis Toxin on Autoimmune Disease J. Immunol., September 1, 2003; 171(5): 2314 - 2319. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-H. Sonoda, Y. Sasa, H. Qiao, C. Tsutsumi, T. Hisatomi, S. Komiyama, T. Kubota, T. Sakamoto, Y.-I. Kawano, and T. Ishibashi Immunoregulatory Role of Ocular Macrophages: The Macrophages Produce RANTES to Suppress Experimental Autoimmune Uveitis J. Immunol., September 1, 2003; 171(5): 2652 - 2659. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. D. Dick, D. Carter, M. Robertson, C. Broderick, E. Hughes, J. V. Forrester, and J. Liversidge Control of myeloid activity during retinal inflammation J. Leukoc. Biol., August 1, 2003; 74(2): 161 - 166. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Hou, Y. Wu, S. Sun, M. Shi, Y. Sun, C. Yang, G. Pei, Y. Gu, C. Zhong, and B. Sun Pertussis Toxin Enhances Th1 Responses by Stimulation of Dendritic Cells J. Immunol., February 15, 2003; 170(4): 1728 - 1736. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Kitaichi, S. Kotake, T. Morohashi, K. Onoe, S. Ohno, and A. W. Taylor Diminution of experimental autoimmune uveoretinitis (EAU) in mice depleted of NK cells J. Leukoc. Biol., December 1, 2002; 72(6): 1117 - 1121. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Namba, N. Kitaichi, T. Nishida, and A. W. Taylor Induction of regulatory T cells by the immunomodulating cytokines {alpha}-melanocyte-stimulating hormone and transforming growth factor-{beta}2 J. Leukoc. Biol., November 1, 2002; 72(5): 946 - 952. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Broderick, R. M. Hoek, J. V. Forrester, J. Liversidge, J. D. Sedgwick, and A. D. Dick Constitutive Retinal CD200 Expression Regulates Resident Microglia and Activation State of Inflammatory Cells during Experimental Autoimmune Uveoretinitis Am. J. Pathol., November 1, 2002; 161(5): 1669 - 1677. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. B. Su, P. B. Silver, M. Zhang, C.-C. Chan, and R. R. Caspi Pertussis Toxin Inhibits Induction of Tissue-Specific Autoimmune Disease by Disrupting G Protein-Coupled Signals J. Immunol., July 1, 2001; 167(1): 250 - 256. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Szpak, J.-C. Vieville, T. Tabary, M.-C. Naud, M. Chopin, C. Edelson, J. H. M. Cohen, J. Dausset, Y. de Kozak, and M. Pla Spontaneous retinopathy in HLA-A29 transgenic mice PNAS, February 8, 2001; (2001) 51595998. [Abstract] [Full Text] |
||||
![]() |
H.-R. Jiang, X.-q. Wei, W. Niedbala, L. Lumsden, F. Y. Liew, and J. V. Forrester IL-18 Not Required for IRBP Peptide-Induced EAU: Studies in Gene-Deficient Mice Invest. Ophthalmol. Vis. Sci., January 1, 2001; 42(1): 177 - 182. [Abstract] [Full Text] |
||||
![]() |
A A Q Araujo, A P Wells, A D Dick, and J V Forrester Early treatment with cyclosporin in serpiginous choroidopathy maintains remission and good visual outcome Br. J. Ophthalmol., September 1, 2000; 84(9): 979 - 982. [Abstract] [Full Text] |
||||
![]() |
K. Ohta, S. Yamagami, A. W. Taylor, and J. W. Streilein IL-6 Antagonizes TGF-{beta} and Abolishes Immune Privilege in Eyes with Endotoxin-Induced Uveitis Invest. Ophthalmol. Vis. Sci., August 1, 2000; 41(9): 2591 - 2599. [Abstract] [Full Text] |
||||
![]() |
D. KENT, S. A VINORES, and P. A CAMPOCHIARO Macular oedema: the role of soluble mediators Br. J. Ophthalmol., May 1, 2000; 84(5): 542 - 545. [Full Text] |
||||
![]() |
K. Ohta, B. Wiggert, S. Yamagami, A. W. Taylor, and J. W. Streilein Analysis of Immunomodulatory Activities of Aqueous Humor from Eyes of Mice with Experimental Autoimmune Uveitis J. Immunol., February 1, 2000; 164(3): 1185 - 1192. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-R. Jiang, L. Lumsden, and J. V. Forrester Macrophages and Dendritic Cells in IRBP-Induced Experimental Autoimmune Uveoretinitis in B10RIII Mice Invest. Ophthalmol. Vis. Sci., December 1, 1999; 40(13): 3177 - 3185. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. B. Silver, C.-C. Chan, B. Wiggert, and R. R. Caspi The Requirement for Pertussis to Induce EAU Is Strain-Dependent: B10.RIII, but Not B10.A Mice, Develop EAU and Th1 Responses to IRBP without Pertussis Treatment Invest. Ophthalmol. Vis. Sci., November 1, 1999; 40(12): 2898 - 2905. [Abstract] [Full Text] [PDF] |
||||
![]() |
G.G. Burrows, J.W. Chang, H-P. Bachinger, D.N. Bourdette, H. Offner, and A.A. Vandenbark Design, engineering and production of functional single-chain T cell receptor ligands Protein Eng. Des. Sel., September 1, 1999; 12(9): 771 - 778. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Ohta, B. Wiggert, A. W. Taylor, and J. W. Streilein Effects of Experimental Ocular Inflammation on Ocular Immune Privilege Invest. Ophthalmol. Vis. Sci., August 1, 1999; 40(9): 2010 - 2018. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Sun, S.-H. Sun, C.-C. Chan, B. Wiggert, and R. R. Caspi Autoimmunity to a pathogenic retinal antigen begins as a balanced cytokine response that polarizes towards type 1 in a disease-susceptible and towards type 2 in a disease-resistant genotype Int. Immunol., August 1, 1999; 11(8): 1307 - 1312. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S. Gregerson, J. W. Torseth, S. W. McPherson, J. P. Roberts, T. Shinohara, and D. J. Zack Retinal Expression of a Neo-Self Antigen, {beta}-Galactosidase, Is Not Tolerogenic and Creates a Target for Autoimmune Uveoretinitis J. Immunol., July 15, 1999; 163(2): 1073 - 1080. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E. Egwuagu, J. Sztein, R. M. Mahdi, W. Li, C. Chao-Chan, J. A. Smith, P. Charukamnoetkanok, and A. B. Chepelinsky IFN-{gamma} Increases the Severity and Accelerates the Onset of Experimental Autoimmune Uveitis in Transgenic Rats J. Immunol., January 1, 1999; 162(1): 510 - 517. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. G. Burrows, B. F. Bebo Jr., K. L. Adlard, A. A. Vandenbark, and H. Offner Two-Domain MHC Class II Molecules Form Stable Complexes with Myelin Basic Protein 69-89 Peptide That Detect and Inhibit Rat Encephalitogenic T Cells and Treat Experimental Autoimmune Encephalomyelitis J. Immunol., December 1, 1998; 161(11): 5987 - 5996. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. D. Moudgil, J. Wang, V. P. Yeung, and E. E. Sercarz Heterogeneity of the T Cell Response to Immunodominant Determinants Within Hen Eggwhite Lysozyme of Individual Syngeneic Hybrid F1 Mice: Implications for Autoimmunity and Infection J. Immunol., December 1, 1998; 161(11): 6046 - 6053. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Szpak, J.-C. Vieville, T. Tabary, M.-C. Naud, M. Chopin, C. Edelson, J. H. M. Cohen, J. Dausset, Y. de Kozak, and M. Pla Spontaneous retinopathy in HLA-A29 transgenic mice PNAS, February 27, 2001; 98(5): 2572 - 2576. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |